2025 HCPCS Code J0651
Injection, levothyroxine sodium (fresenius kabi), not therapeutically equivalent to j0650, 10 mcg
TAGS: equivalent sodium levothyroxine therapeuticallyShort Description | Inj, levothyroxine, freskabi |
HCPCS Action Code | C - Change in long description of procedure or modifier code |
HCPCS Coverage Code | C - Carrier judgment |
HCPCS Code Added Date | April 01, 2024 |
HCPCS Action Effective Date | July 01, 2024 |
HCPCS Pricing Indicator Code | 51 - Drugs |
HCPCS Type Of Service Code | 1 - Medical care |
HCPCS Multiple Pricing Indicator Code | A - Not applicable as HCPCS priced under one methodology |
HCPCS Anesthesia Base Unit Quantity | 0 |
HCPCS Coverage Issues Manual Reference Section Number |
Check Similar HCPCS Codes
- J9255 - Inj, methotrexate (accord)
- J9258 - Paclitaxel (teva)
- J9259 - Paclitaxel (american regent)
- J9260 - Inj methotrexate sodium 50mg
- J9261 - Nelarabine injection
- J9262 - Inj, omacetaxine mep, 0.01mg
- J9263 - Oxaliplatin
- J9264 - Paclitaxel protein bound
- J9265 - Paclitaxel injection
- J9266 - Pegaspargase injection
- J9267 - Paclitaxel injection
- J9268 - Pentostatin injection
- J9269 - Inj. tagraxofusp-erzs 10 mcg
- J9270 - Plicamycin (mithramycin) inj
- J9271 - Inj pembrolizumab
- J9272 - Inj, dostarlimab-gxly, 10 mg
- J9273 - Inj tisotu vedotin-tftv, 1mg
- J9274 - Inj, tebentafusp-tebn, 1 mcg
- J9280 - Mitomycin injection
- J9281 - Mitomycin instillation